慢性硬膜下血肿钻孔引流术后骨膜下引流与硬膜下引流的比较:系统评价与Meta分析
该系统评价与Meta分析纳入10项研究共3169例慢性硬膜下血肿患者,比较骨膜下引流(SPD)与硬膜下引流(SDD)的疗效与安全性。SPD组复发率较SDD组显著降低(OR 0.73,95%CI 0.58-0.92),脑实质损伤风险亦较低(OR 0.29,95%CI 0.11-0.76),良好结局与不良事件率两组无显著差异。作者认为SPD可能更安全且可能更有效,但需更多大型随机对照试验进一步研究。
要点
- 慢性硬膜下血肿钻孔引流术后,骨膜下引流(SPD)组复发率显著低于硬膜下引流(SDD)组(OR 0.73,95%CI 0.58-0.92)。
- SPD组脑实质损伤风险显著低于SDD组(OR 0.29,95%CI 0.11-0.76)。
- 两组良好结局、死亡率、癫痫发作及手术感染率均无显著差异。
核心结论
- 本Meta分析结果提示,骨膜下引流(SPD)治疗慢性硬膜下血肿较硬膜下引流(SDD)更安全,且可能更有效。
- 作者指出需要更多大型随机对照试验来研究SPD在慢性硬膜下血肿管理中的应用。
研究设计与样本
- 遵循PRISMA指南的系统评价与Meta分析,检索MEDLINE、EMBASE和Cochrane Central至2019年9月,纳入10项研究共3169例患者。
主要发现
- SPD组复发率较SDD组显著降低(OR 0.73,95%CI 0.58-0.92;I²=14%;P=0.007)。
- SPD组与SDD组良好结局无显著差异(OR 1.29,95%CI 1-1.68;I²=0%;P=0.05)。
- SPD组脑实质损伤风险较SDD组显著降低(OR 0.29,95%CI 0.11-0.76;I²=0%;P=0.01)。
- 两组不良事件率(包括死亡率、癫痫发作和手术感染)无显著差异。
临床怎么用
- 作者认为,骨膜下引流(SPD)治疗慢性硬膜下血肿较硬膜下引流(SDD)更安全,且可能更有效。
- 作者建议需要更多大型随机对照试验来研究SPD在慢性硬膜下血肿管理中的应用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The use of drains has been considered to be superior to no drains after burr hole drainage of chronic subdural hematomas (CSDHs). Therefore, routine placement of a subdural drain (SDD) is supported by most neurosurgeons. However, whether the drain location after CSDH burr hole evacuation influences patient outcomes is unclear. Therefore, we compared the efficacy and safety of subperiosteal drains (SPDs) with those of SDDs for patients with CSDHs. METHODS: Using the PRISMA (preferred reporting items for systematic reviews and meta-analyses) guidelines, eligible studies reported up to September 2019 were identified through a search of MEDLINE, EMBASE, and Cochrane Central. Pooled estimates, confidence intervals (CIs), and odds ratios (ORs) were calculated for all outcomes. RESULTS: Ten studies with 3169 patients were included. The use of a SPD after CSDH burr hole drainage resulted in a significant decrease in recurrences compared with the use of a SDD (OR, 0.73; 95% CI, 0.58-0.92; I2, 14%; P = 0.007). No significant differences were identified between the SPD and SDD groups in the favorable outcomes (OR, 1.29; 95% CI, 1-1.68; I2, 0%; P = 0.05). Adverse event rates, including mortality, seizures, and surgical infection, were not significantly different between the 2 groups. However, the use of SPDs was associated with a lower risk of parenchymal injuries compared with SDDs (OR, 0.29; 95% CI, 0.11-0.76; I2, 0%; P = 0.01). CONCLUSIONS: The results from the present meta-analysis suggest that the use of an SPD is safer and might be more effective than an SDD in the treatment of CSDH. However, more large randomized controlled trials are needed to investigate the use of SPDs in the management of CSDH.
引用
- Ding H, Liu S, Quan X, et al. Subperiosteal versus Subdural Drain After Burr Hole Drainage for Chronic Subdural Hematomas: A Systematic Review and Meta-Analysis. World Neurosurg. 2020. PMID: 31927124. doi:10.1016/j.wneu.2019.12.180
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。